Boston Partners Acquires 74,776 Shares of Envista Holdings Co. (NYSE:NVST)

Boston Partners grew its stake in shares of Envista Holdings Co. (NYSE:NVSTGet Rating) by 2.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,997,185 shares of the company’s stock after buying an additional 74,776 shares during the quarter. Boston Partners owned 1.86% of Envista worth $134,875,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Cornercap Investment Counsel Inc. lifted its position in shares of Envista by 7.5% in the 3rd quarter. Cornercap Investment Counsel Inc. now owns 30,718 shares of the company’s stock worth $1,284,000 after purchasing an additional 2,142 shares during the period. Hancock Whitney Corp lifted its holdings in Envista by 1.9% in the third quarter. Hancock Whitney Corp now owns 45,064 shares of the company’s stock worth $1,884,000 after buying an additional 825 shares during the period. Brown Advisory Inc. bought a new stake in Envista during the 4th quarter valued at approximately $414,000. Tamarack Advisers LP purchased a new position in shares of Envista during the 3rd quarter worth approximately $1,881,000. Finally, Front Street Capital Management Inc. raised its position in shares of Envista by 0.5% in the 3rd quarter. Front Street Capital Management Inc. now owns 139,657 shares of the company’s stock worth $5,839,000 after acquiring an additional 739 shares in the last quarter.

Shares of Envista stock traded down $0.21 during trading hours on Monday, hitting $45.63. The company’s stock had a trading volume of 1,700 shares, compared to its average volume of 1,824,951. The company has a market cap of $7.38 billion, a PE ratio of 23.88, a PEG ratio of 1.75 and a beta of 1.59. Envista Holdings Co. has a 12-month low of $37.60 and a 12-month high of $52.03. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.30 and a current ratio of 1.52. The business has a 50 day moving average price of $47.45 and a two-hundred day moving average price of $43.91.

Envista (NYSE:NVSTGet Rating) last released its quarterly earnings results on Wednesday, February 9th. The company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.04. The business had revenue of $651.80 million during the quarter, compared to analysts’ expectations of $633.22 million. Envista had a return on equity of 8.96% and a net margin of 12.57%. During the same quarter last year, the business posted $0.56 EPS. As a group, research analysts anticipate that Envista Holdings Co. will post 1.99 earnings per share for the current year.

In related news, CEO Amir Aghdaei sold 114,702 shares of the business’s stock in a transaction on Thursday, March 17th. The stock was sold at an average price of $49.01, for a total transaction of $5,621,545.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Howard H. Yu sold 3,598 shares of the stock in a transaction on Friday, February 25th. The stock was sold at an average price of $47.81, for a total value of $172,020.38. The disclosure for this sale can be found here. Insiders sold 155,488 shares of company stock worth $7,608,414 in the last 90 days. 0.82% of the stock is currently owned by company insiders.

A number of research firms have issued reports on NVST. Morgan Stanley increased their price objective on Envista from $52.00 to $56.00 and gave the stock an “overweight” rating in a report on Monday, April 4th. Piper Sandler raised their price target on Envista from $47.00 to $50.00 in a report on Thursday, February 10th. Zacks Investment Research downgraded Envista from a “buy” rating to a “hold” rating in a report on Thursday, February 24th. Finally, Robert W. Baird restated an “outperform” rating and set a $54.00 target price on shares of Envista in a research note on Tuesday, April 5th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to, the stock currently has a consensus rating of “Buy” and a consensus price target of $51.83.

Envista Company Profile (Get Rating)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.

Featured Articles

Want to see what other hedge funds are holding NVST? Visit to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTGet Rating).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with's FREE daily email newsletter.